Related Experiment Video
Updated: Jul 6, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Structure and mode of action of clostridial glucosylating toxins: the ABCD model
1Institut für Experimentelle und Klinische Pharmakologie und Toxikologie der Albert-Ludwigs-Universität Freiburg, Otto-Krayer-Haus, Albertstrasse 25, D-79104 Freiburg, Germany.
Abstract:
Toxins A and B, which are the major virulence factors of antibiotic-associated diarrhea and pseudomembranous colitis caused by Clostridium difficile, are the prototypes of the family of clostridial glucosylating toxins. The toxins inactivate Rho and Ras proteins by glucosylation. Recent findings on the autocatalytic processing of the toxins and analysis of the crystal structures of their domains have made a revision of the current model of their actions on the eukaryotic target cells necessary.
Insights
Clostridium difficile toxins A and B, potent virulence factors, inactivate host proteins via glucosylation. New structural and processing data necessitate revising how these toxins affect target cells.
Area of Science:
- Microbiology
- Molecular Biology
- Toxicology
Background:
- Clostridium difficile toxins A and B are key virulence factors in antibiotic-associated diarrhea and pseudomembranous colitis.
- These toxins belong to the family of clostridial glucosylating toxins.
- They function by inactivating Rho and Ras proteins through glucosylation.
Purpose of the Study:
- To revise the current model of how Clostridium difficile toxins A and B act on eukaryotic target cells.
- To incorporate recent findings on toxin processing and structure into a new mechanistic understanding.
Main Methods:
- Analysis of crystal structures of toxin domains.
- Investigation of autocatalytic processing mechanisms of the toxins.
Main Results:
- Recent structural and processing data provide new insights into toxin mechanisms.
- These findings challenge and necessitate the revision of existing models.
Conclusions:
- A revised model is required to accurately describe the actions of Clostridium difficile toxins on eukaryotic cells.
- Understanding these mechanisms is crucial for developing therapeutic strategies against C. difficile infections.
More Related Videos
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
15:05Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
Related Concept Videos
Botulism
Bacterial Toxins
Tetanus
Inhibitors of Gram-positive Cell Wall Synthesis
Determinants of Bacterial Pathogenicity and Virulence
Diphtheria